RESPONSE OF HUMAN-IMMUNODEFICIENCY-VIRUS-ASSOCIATED NEUROLOGICAL DISEASE TO 3'-AZIDO-3'-DEOXYTHYMIDINE

This publication has 10 references indexed in Scilit:

• Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: A Novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases
  Clinical Pharmacology & Therapeutics, 1987
• Positron Emission Tomography in Dementia of the Alzheimer Type
  Archives of internal medicine (1960), 1986
• The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
  Science, 1986
• The AIDS dementia complex: II. Neuropathology
  Annals of Neurology, 1986
• The AIDS dementia complex: I. Clinical features
  Annals of Neurology, 1986
• ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX
  The Lancet, 1986
• Intra-Blood–Brain-Barrier Synthesis of HTLV-III-Specific IgG in Patients with Neurologic Symptoms Associated with AIDS or AIDS-Related Complex
  New England Journal of Medicine, 1985
• Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency Syndrome
  New England Journal of Medicine, 1985
• 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
  Proceedings of the National Academy of Sciences, 1985
• HTLV-III Infection in Brains of Children and Adults with AIDS Encephalopathy
  Science, 1985